Showing results (1261-1270 of 2,357) with videos related to

Sort By:
Pageof 236
Clinical Neuropharmacology|August 1, 2009
High doses of rotigotine transdermal patch: results of an open-label, dose-escalation trial in patients with advanced-stage, idiopathic Parkinson diseaseIvan Rektor, Tomislav Babic, Bernard Boothmann, et al.
Clinical Neuropharmacology|August 1, 2009
The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophreniaSung-Wan Kim, Il-Seon Shin, Jae-Min Kim, et al.
Clinical Neuropharmacology|August 1, 2009
Idiopathic hemifacial spasm responsive to zonisamide: a case reportAntonio Siniscalchi, Luca Gallelli, Caterina Palleria, et al.
Clinical Neuropharmacology|July 22, 2009
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patientsVanessa K Hinson, Christopher G Goetz, Sue Leurgans, et al.
Clinical Neuropharmacology|July 22, 2009
Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophreniaSung-Wan Kim, Il-Seon Shin, Jae-Min Kim, et al.
Clinical Neuropharmacology|August 12, 2009
Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trialArthur S Walters, William G Ondo, Clete A Kushida, et al.
Clinical Neuropharmacology|August 12, 2009
Fluoxetine blocks myotonic runs and reverts abnormal surface electromyogram pattern in patients with myotonic dystrophy type 1Carmelo Chisari, Rosaria Licitra, Monica Pellegrini, et al.
Clinical Neuropharmacology|March 18, 2011
Efficacy and tolerability of pregabalin versus topiramate in the prophylaxis of chronic daily headache with analgesic overuse: an open-label prospective studyBarbara Rizzato, Giorgia Leone, Giulia Misaggi, et al.
Clinical Neuropharmacology|March 18, 2011
Adverse reactions to antiepileptic drugs in epileptic outpatients: a cross-sectional study in iranSoha Namazi, Afshin Borhani-Haghighi, Iman Karimzadeh
Clinical Neuropharmacology|June 1, 1994
Treatment with botulinum toxin injections does not change brainstem interneuronal excitability in patients with cervical dystoniaJ Valls-Sole, E S Tolosa, M J Marti, et al.
Pageof 236